© 2021 KOMAND Consulting
CZECH REPUBLIC
Population: 10,649,800
GDP/Capita: USD$40,585
Wholesale Medical Flower Price/Gram: CZK143.75Kč (€5.65)
Capped by Czech Ministry of Health
Current Med/Rec Usage (15-64yrs): 8.9% (2017 Prevalence)
Prescription Count Ytd 2021
12,251
Prescription Count 2020
14,167
Prescription Count
d
Sources : European Monitoring Centre for Drugs & Drug Addiction (EMCDDA)
Eurostat, IMF, SAKL.cz
Czech Medicinal Cannabis Import and Distribution
Source : SAKL, lecebnekonopi.webnode.cz
STATUS
Introduction of medicinal cannabis programme in 2013
There is one Czech Licenced Producer, Elkoplast
All pharmacies can prepare and deliver cannabis from imports
Public health insurance reimburses 90% of products containing
cannabis for medical use
NEWS
New rules for the cultivation and export of medical cannabis
Motagon Introduces GG4 Medical Cannabis to the Czech Market
Government approves amendment to increase domestic growers
Status Quo & Recent News
Patients
Products
Product
THC/CBD
per gram of flower
Package
Size
Package cost
Wholesale
with VAT
Elkoplast Balanced
(Czech produced dried flower)
60mg / 75mg 10g
€63
1,700Kč
Elkoplast THC Dominant
(Czech produced dried flower)
190mg / 0 10g
€63
1,700Kč
Bedrobinol
(Import Dried Flower)
135mg / 0 5g
n/a
Tilray THC10:CBD10
(Import Dried Flower)
100mg / 100mg 5g
€46
1,250Kč
Tilray THC 16
(Import Milled Dried Flower)
160mg / 0 10g
€74
2,000Kč
Spectrum Red No 4
(Import Dried Flower)
210mg / 0 5g
€24
650Kč
Spectrum Red No 2
(Import Dried Flower)
190mg / 0 5g
€24
650Kč
Spectrum Penelope
(Import Dried Flower)
100mg / 80mg 5g
€24
650Kč
Spectrum Green No 2
(Import Dried Flower)
70mg / 100mg 5g
€24
650Kč
List of Products – Dried Flower
a
a
Perrmitted forms of medical cannabis are outlined in 236/2015 Coll. from the
Ministry of Health
The Czech produced dried flower is grown by Elkoplast under contract for the
SUKL. The price charged by Elkoplast is 139Kč. Alliance is the wholesale
distributor for SUKL cannabis
All pharmacies can prepare and deliver cannabis from imports, provided the
product is delivered to them by a licenced importer (e.g. Czech Medical Herbs) via
a wholesale distributor (e.g. Phoenix)
Back to Europe
Product Channels
Q3-19
Q4-19
Q1-20
Q2-20
Q3-20
Q4-20
Q1-21
Q2-21
1047
1494
2972
3233
3962
4001
4323
4938
354
434
796
1,104
1,199
1,103
1,324
1,402
Medical Cannabis dispensing and patients
e
Prescriptionsinthequarterlyperiod
UniquePatientspermonth
e
Data provided by the SAKL
Public medical insurance coverage for cannabis started in Q1-2020
Average count of doctors (per month) prescribing stands at 118 in Nov
2020
Guidance - Indications and Specialised
Qualification of the Prescribing Physician
h
Indications Specialised
Qualifications
Chronic pain-relieving pain (especially
pain associated with cancer, pain
associated with degenerative diseases
of the locomotive system, systemic
connective tissue disease and
immunopathological conditions,
neuropathic pain, glaucoma pain)
- Clinical oncology
- Radiation oncology
- Neurology
- Palliative medicine
- Pain treatment
- Rheumatology
- Orthopedics
- Infectious medicine
- Internal medicine
- Ophthalmology
- Dermatovenerology
- Geriatrics
Spasticity and associated pain in
multiple sclerosis or spinal cord injury,
painless persistent spasticity severely
limiting movement and mobility, or
patient breathing, involuntary
neurological disease kinetics and
other medical complications
originating from a neurological
disease, or spinal cord injury with
spinal cord injury, brain injury,
neurological tremor caused by
Parkinson's disease and other
neurological problems at the
discretion of the treating physician
- Neurology
- Geriatrics
Nausea, vomiting, appetite
stimulation associated with cancer
treatment or HIV treatment
- Clinical oncology
- Radiation oncology
- Infectious medicine
- Dermatovenerology
- Geriatrics
Gilles de la Tourette syndrome - Psychiatry
Superficial treatment of dermatoses
and mucosal lesions
- Infectious medicine
- Dermatovenerology
- Geriatrics
h
SAKL - Decree No 236-2015, Annex 3
d
Prescription Count is total prescriptions delivered per 12-month period
2021 Ytd is Jan - Aug 2021
Czech produced batches of medical cannabis
supplied to domestic market – kg of Dried Flower
c
1 2 3 4 5 6 7 8 9 10 11 12
15.5 kg
9.1 kg
4.4 kg
13.7 kg
17.4 kg
13.4 kg
19%THC,0.1%CBD 6%THC,7.5%CBD
c
Elkoplast has the contract to produce medical cannabis for the SUKL
The current contract has Elkoplast delivering THC Dominant and Balanced batches
at 139Kč (excl. VAT) per gram to the SUKL
2016
2018
2019
THCDominant Balanced
Other
Multiplesclerosis
ChronicPain
6.4%
3.4%
90.1%
8.0%
9.0%
83.0%
8.6%
12.5%
79.0%
Czech Condition/Symptom Percentage of
Patient Prescriptions
f
Medical Cannabis Prescribed in Czech Republic
b
kg of dried flower
2016 2017 2018 2019 2020 2021
2.58 kg
1.23 kg
4.80 kg
17.00 kg
66.77 kg
67.82 kg
b
Data provided by the SAKL
2020 2019 2018
Producer SUKL/Importing Company Distribution Company
Elkoplast (Domestic) SUKL (buyer) Alliance Healthcare
Tilray Canada Ltd. Czech Medical Herbs Phoenix
Spectrum Cannabis (Tweed) Canopy Growth Czech s.r.o. Phoenix
Northern Green Canada Motagon s.r.o. -
Bedrocan International B.V. Czech Medical Herbs Phoenix
f
Data provided by the SAKL
11.2 kg
4.2 kg
Last Updated – Oct 2021
2020
State Agency for Medical Cannabis (SAKL)
SAKL grants licenses to grow medical cannabis, purchase of grown
product, distribution and export outside the Czech Republic
State Institute for Drug Control (SUKL)
SUKL regulates the safe production of pharmaceuticals and is
responsible for the surveillance of advertising and marketing
Ministry of Health for Czech Republic
The ministry controls the import of narcotics according to the Act
on Addictive Substances (authorisation body), including cannabis
Regulatory Agencies
Cannabis
Pharma
2021
HerbalTea
OralHerbalmaterial
Capsules
3.0%
6.3%
90.7%
Three most common prescribed dosage forms
of medical cannabis
g
g
Data provided by the SAKL